%D8%AA%D9%84%D9%8A%D9%81_%D9%83%D9%8A%D8%B3%D9%8AFibrosis_qu%C3%ADsticaFibrosi_qu%C3%ADstica%D8%B3%DB%8C%D8%B3%D8%AA%DB%8C%DA%A9_%D9%81%D8%A7%DB%8C%D8%A8%D8%B1%DB%86%D8%B3%D8%B3Cystick%C3%A1_fibr%C3%B3zaFfibrosis_systigCystisk_fibroseMukoviszidose%CE%9A%CF%85%CF%83%CF%84%CE%B9%CE%BA%CE%AE_%CE%AF%CE%BD%CF%89%CF%83%CE%B7Cystic_fibrosisMukoviskozecoFibrosis_qu%C3%ADsticaTs%C3%BCstiline_fibroosFibrosi_kistiko%D9%81%DB%8C%D8%A8%D8%B1%D9%88%D8%B2_%D8%B3%DB%8C%D8%B3%D8%AA%DB%8C%DA%A9Kystinen_fibroosiMucoviscidoseFiobr%C3%B3is_chisteachFibrose_qu%C3%ADstica%D7%A1%D7%99%D7%A1%D7%98%D7%99%D7%A7_%D7%A4%D7%99%D7%91%D7%A8%D7%95%D7%96%D7%99%D7%A1%E0%A4%B8%E0%A4%BF%E0%A4%B8%E0%A5%8D%E0%A4%9F%E0%A4%BF%E0%A4%95_%E0%A4%AB%E0%A4%BE%E0%A4%87%E0%A4%AC%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%B8%E0%A4%BF%E0%A4%B8Ciszt%C3%A1s_fibr%C3%B3zis%D5%91%D5%AB%D5%BD%D5%BF%D5%AB%D5%AF_%D6%86%D5%AB%D5%A2%D6%80%D5%B8%D5%A6Fibrosis_sistikFibrosi_cistica%E5%9A%A2%E8%83%9E%E6%80%A7%E7%B7%9A%E7%B6%AD%E7%97%87%E1%83%99%E1%83%98%E1%83%A1%E1%83%A2%E1%83%A3%E1%83%A0%E1%83%98_%E1%83%A4%E1%83%98%E1%83%91%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98%D0%9C%D1%83%D0%BA%D0%BE%D0%B2%D0%B8%D1%81%D1%86%D0%B8%D0%B4%D0%BE%D0%B7%EB%82%AD%ED%8F%AC%EC%84%B1_%EC%84%AC%EC%9C%A0%EC%A6%9DTejsliemgekrenkdjeCistin%C4%97_fibroz%C4%97Mukoviscidoze%D0%A6%D0%B8%D1%81%D1%82%D0%B8%D1%87%D0%BD%D0%B0_%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%B7%D0%B0Penyakit_Sistik_FibrosisTaaislijmziekteCystisk_fibroseCystisk_fibrose%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8D%E0%AC%9F%E0%AC%BF%E0%AC%95%E0%AD%8D_%E0%AC%AB%E0%AC%BE%E0%AC%87%E0%AC%AC%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8DMukowiscydozaFibrose_c%C3%ADstica
about
P101
Alice MartineauGrégory LemarchalJeanne BarbeyClaire WinelandRole of Genetic Factors in the Development of Lung DiseaseSweat Evaporimeter MeasurementA Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients With Cystic Fibrosis (CFmised, Double-blind, Parallel-group Study of Alginate Oligosaccharide)The Role of Bacteria and Genetic Variations in Cystic FibrosisThe Effectiveness of a Systemic Mindfulness-based Intervention Program in a Cystic Fibrosis ClinicNon Ivasive Prenatal Diagnosis (NIPD) of Cystic FibrosisEvaluating High Flow Humidification Therapy in Patients With Cystic FibrosisClinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished ChildrenMapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung SpecimensEffects of an Exercise Program Among CF Patients With DysglycemiaA Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508delNovel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon MutationsNon-invasive Prenatal Diagnosis of Monogenic Disorders by Linked-reads TechnologyProject 2 Airway Potential Hydrogen (pH) in AsthmaStudy for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic FibrosisRare CFTR Mutation Cell Collection Protocol (RARE)SynRinse Irrigation Pilot (SIP) TrialStudy to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic FibrosisUse of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas AeruginosaThe Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic FibrosisPharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled TobramycinDeposition of Inhaled Prolastin in Cystic Fibrosis PatientsDisclosing a Cystic Fibrosis Diagnosis to a Dating PartnerA Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic FibrosisImproving Vitamin D Status In Cystic FibrosisOpen-Label Phase III Long-Term Safety Trial of LiprotamaseLiprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic InsufficiencyStudy of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseTobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic StudyProlonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis PeopleNasally Delivered Pulmozyme for Sinusitis in Cystic FibrosisLong Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy StudyGenetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)Blood Collection From Individuals With Lung Disease for Genetic Studies
P1050
description
Enfermedad pulmonar genética
@es
Krankheit
@de
Pankreako eta biriketako sortz ...... nezintasuna dira bere sintomak
@eu
afiechyd sy'n ymwneud mwcws
@cy
autosomal recessive disease th ...... s that can damage many organs.
@en
genetika malsano
@eo
maladie génétique
@fr
malattia dell'apparato respiratorio
@it
recessiv genetisk sjukdom
@sv
Болезнь
@ru
name
Cistinė fibrozė
@lt
Cistična fibroza
@sh
Cistična fibroza
@sl
Cistična fibroza
@sr-el
Cisztás fibrózis
@hu
Cystická fibróza
@sk
Fibrose quística
@gl
Fibrosi kistiko
@eu
Fibrosis quística
@ast
Fibrosis sistik
@id
type
label
Cistinė fibrozė
@lt
Cistična fibroza
@sh
Cistična fibroza
@sl
Cistična fibroza
@sr-el
Cisztás fibrózis
@hu
Cystická fibróza
@sk
Fibrose quística
@gl
Fibrosi kistiko
@eu
Fibrosis quística
@ast
Fibrosis sistik
@id
altLabel
C.F.
@he
C.F.
@tl
CF
@en
CF
@nl
CF
@tl
CYSTIC FIBROSIS
@en
CYSTIC FIBROSIS; CF
@en
Cystic fibrosis
@nl
Cystic fibrosis
@nn
Cystic fibrosis
@tl
prefLabel
Cistinė fibrozė
@lt
Cistična fibroza
@sh
Cistična fibroza
@sl
Cistična fibroza
@sr-el
Cisztás fibrózis
@hu
Cystická fibróza
@sk
Fibrose quística
@gl
Fibrosi kistiko
@eu
Fibrosis quística
@ast
Fibrosis sistik
@id